FDA warns Novo Nordisk over unreported potential Ozempic side effects

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.

from Us - CBSNews.com https://ift.tt/4OTVUcH
via IFTTT